You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Claims for Patent: 7,550,440

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,550,440

Title:	Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Abstract:	Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
Inventor(s):	Manetta; Vincent (Bordentown, NJ), Watkins; Gary R. (Piscataway, NJ)
Assignee:	Galderma S.A. (Cham, CH)
Application Number:	11/255,910
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,550,440
Patent Claims:	1. A regime or regimen for the treatment of rosacea, comprising topically applying onto the affected skin area of an individual in need of such treatment, the topical pharmaceutical emulsion which comprises: TABLE-US-00010 Ivermectin 1.00 Glycerol 4.0 Acrylate C10-30 alkyl acrylate 0.2 crosspolymer Methyl para-hydroxybenzoate 0.2 Disodium EDTA 0.05 Citric acid monohydrate 0.05 Isopropyl palmitate 4.0 Cetyl alcohol 3.5 Stearyl monostearate 2.5 Oleyl alcohol 2.0 Ceteareth-20 3.0 Sorbitan monostearate 2.0 Dimethicone 200 20 cs 0.5 Propyl para-hydroxybenzoate 0.1 Propylene glycol 2.0 Phenoxyethanol 1.0 10% sodium hydroxide qs pH Water qs 100 as % by weight relative to the total weight of the emulsion. 2. A regime or regimen for the treatment of rosacea, comprising topically applying onto the affected skin area of an individual in need of such treatment, the topical pharmaceutical emulsion which comprises: TABLE-US-00011 Ivermectin 1.4 Glycerol 4.0 Acrylate C10-30 alkyl acrylate 0.2 crosspolymer Methyl para-hydroxybenzoate 0.2 Disodium EDTA 0.05 Citric acid monohydrate 0.05 Isopropyl palmitate 4.0 Cetyl alcohol 3.5 Stearyl alcohol 2.5 Oleyl alcohol 2.0 Ceteareth-20 3.0 Sorbitan monostearate 2.0 Dimethicone 200 20 cs 0.5 Propyl para-hydroxybenzoate 0.1 Propylene glycol 2.0 Phenoxyethanol 1.0 10% sodium hydroxide qs pH Water qs 100 as % by weight relative to the total weight of the emulsion. 3. The topically applicable, stable pharmaceutical emulsion comprising: TABLE-US-00012 Ivermectin 1.00 Glycerol 4.0 Acrylate C10-30 alkyl acrylate 0.2 crosspolymer Methyl para-hydroxybenzoate 0.2 Disodium EDTA 0.05 Citric acid monohydrate 0.05 Isopropyl palmitate 4.0 Cetyl alcohol 3.5 Stearyl alcohol 2.5 Oleyl alcohol 2.0 Ceteareth-20 3.0 Sorbitan monostearate 2.0 Dimethicone 200 20 cs 0.5 Propyl para-hydroxybenzoate 0.1 Propylene glycol 2.0 Phenoxyethanol 1.0 10% sodium hydroxide qs pH Water qs 100 as % by weight relative to the total weight of the emulsion. 4. The topically applicable, stable pharmaceutical emulsion comprising: TABLE-US-00013 Ivermectin 1.4 Glycerol 4.0 Acrylate C10-30 alkyl acrylate 0.2 crosspolymer Methyl para-hydroxybenzoate 0.2 Disodium EDTA 0.05 Citric acid monohydrate 0.05 Isopropyl palmitate 4.0 Cetyl alcohol 3.5 Stearyl alcohol 2.5 Oleyl alcohol 2.0 Ceteareth-20 3.0 Sorbitan monostearate 2.0 Dimethicone 200 20 cs 0.5 Propyl para-hydroxybenzoate 0.1 Propylene glycol 2.0 Phenoxyethanol 1.0 10% sodium hydroxide qs pH Water qs 100 as % by weight relative to the total weight of the emulsion.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.